Overview
Lacticaseibacillus paracasei (formerly Lactobacillus paracasei) is a Gram-positive, facultatively anaerobic bacterium commonly found in the human gut, oral cavity, and on the skin. Reclassified in 2020 within the Lacticaseibacillus genus, this species belongs to the L. casei group alongside Lactobacillus casei and Lactobacillus rhamnosus. It is one of the most widely studied probiotic species for allergy management, with particular relevance to allergic rhinitis and infant immune development.
Multiple well-characterized strains of L. paracasei have been developed for commercial probiotic applications, each with distinct clinical profiles. The species is commonly found in both the human microbiome and in fermented foods, giving it a dual presence as both a natural commensal and a food-associated microorganism.
Classification
L. paracasei belongs to the family Lactobacillaceae within the phylum Bacillota (formerly Firmicutes). It is a heterofermentative lactic acid bacterium capable of fermenting a wide range of carbohydrates. The species is closely related to L. casei, and historical taxonomic confusion between the two has been largely resolved through molecular typing methods. The 2020 reclassification placed it in the newly established genus Lacticaseibacillus, abbreviated as Lc. paracasei.
Key Characteristics
A defining feature of L. paracasei is its capacity to modulate the Th1/Th2 immune balance, which may underlie its anti-allergic properties. Strain LP-33 has been shown in clinical trials to significantly improve quality of life scores in individuals with allergic rhinitis after 30 days of supplementation via fermented milk. The species also demonstrates strong acid and bile tolerance, good adhesion to intestinal epithelial cells, and antimicrobial activity against various pathogens.
Interestingly, certain strains such as LB-8 produce exopolysaccharides (EPS) that may function as prebiotics, promoting the growth of beneficial species like Bifidobacterium breve at levels comparable to the established prebiotic inulin. This cross-species prebiotic activity suggests that L. paracasei may support the broader microbiome ecosystem beyond its own direct effects.
Health Significance
The health significance of L. paracasei is most firmly established in allergy and immune modulation. Strain LP-33 represents one of the most studied probiotic interventions for allergic rhinitis, with research indicating meaningful improvements in symptom burden and quality of life through Th1/Th2 immune rebalancing. For infant health, strain F19 has shown potential to reduce atopic manifestations when included in infant formula, with studies suggesting reduced eczema incidence and fewer antibiotic prescriptions during follow-up.
Strain ST11 has been investigated for atopic dermatitis and skin health applications, reflecting the growing understanding that gut microbiome composition may influence skin conditions through the gut-skin axis. While the evidence base continues to expand, current research suggests that L. paracasei may be particularly valuable for individuals with allergic conditions, though results may vary by strain and clinical context.